All Comments by Nikolaos K. Robakis

  1. Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein.
  2. Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease.
  3. Evidence that intramolecular associations between presenilin domains are obligatory for endoproteolytic processing.
  4. Immunologic treatment of Alzheimer's disease.
  5. The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.
  6. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease.
  7. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele.
  8. Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures.
  9. C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.
  10. Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice.
  11. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid.
  12. Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients.
  13. Carnosine, a protective, anti-ageing peptide?
  14. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion.
  15. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy.